Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Minnesota for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Minnesota only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Minnesota (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Alexander Ringeisen (NPI 1710323142)

Field	Value
Entity Type	Individual
Organization	Alexander Ringeisen
Address	2080 Woodwinds Dr Ste 230
City	Woodbury
State	MN
ZIP	55125
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	May 13, 2013

Payer Source	Total Paid
Medicare	$1.1M
Medicaid	$0

Key Findings

This provider’s Medicare footprint is modest in scale — total Medicare revenue of $1.1M with no Medicaid billing on file — meaning the practice is effectively single‑payer (Medicare) in the public programs data set. The absence of any Medicaid activity should be flagged for analysts interested in payer mix or access to lower‑income populations.

Revenue is highly concentrated in a small number of drugs and procedures: the precomputed top three Medicare codes account for 73.0% of the provider’s Medicare revenue. Specifically, J0178 represents $413.8K (38.7%) and J2777 represents $285.4K (26.7%), with 67028 contributing $81.2K (7.6%), demonstrating that a handful of items drive the majority of billed revenue.

The code mix is consistent with a retina specialist whose operation is centered on intravitreal pharmacologic therapy and retina‑specific procedures: high revenue and claim counts for J0178 (598 claims, $692 avg paid/claim, $413.8K) and J2777 (9.8K claims, $29 avg paid/claim, $285.4K) indicate routine anti‑VEGF and related injections, while 92134 (1.4K claims, $30 avg paid/claim, $42.8K) shows substantial retinal imaging use supporting ongoing monitoring.

Surgical retina capacity is evident and relatively prominent: 67041 (54 claims, $885 avg paid/claim, $47.8K) ranks #22 of 461 providers nationally (95th percentile) and is labeled as notably above typical national volume, indicating this provider performs membrane peel/retinal membrane surgery at a materially higher rate than peers. 67036 (40 claims, $625 avg paid/claim, $25K) and 67042 (20 claims, $873 avg paid/claim, $17.5K) further support an active surgical practice.

For the high‑revenue injection codes the provider’s national competitive standing is generally modest: J0178 ranks #1777 of 3204 (44th percentile; typical, unremarkable volume) and J2777 ranks #1022 of 2039 (50th percentile; typical, unremarkable volume), so while these codes drive dollars locally they do not place the provider among national leaders for those specific drug administrations. Conversely, retinal imaging (92134) ranks #1604 of 26868 (94th percentile; notably above typical national volume), signaling a comparatively strong position in diagnostic imaging.

Evaluation & management activity contributes only a modest share of revenue relative to procedures and drug injections: 99214 accounts for $53.1K (5.0% of Medicare revenue) and 99213 contributes $4.3K (0.4%), indicating clinical encounters are largely driven by procedure‑based follow‑ups rather than high volumes of standalone office E/M services. This pattern is typical for retina subspecialists whose visits often center on injections and imaging.

The provider’s business is materially reliant on anti‑VEGF and related intravitreal therapies: J0178 and J2777 together account for 65.4% of Medicare revenue (38.7% + 26.7% as reported) and, with the top three codes totaling 73.0%, reimbursement or utilization changes for these codes could have an outsized effect on revenue. Analysts should note this concentration when modeling payer reimbursement shifts or formulary changes.

Provider tenure is established but not long‑standing: NPI enumeration on 2013-05-13 (~13 years ago) suggests the practice has had over a decade to build referral relationships and procedural volume, consistent with the combination of high imaging throughput and above‑typical surgical volume in select retina procedures.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	600	$690	$413.8K
J2777	Injection, faricimab‑svoa, 0.1 mg	9,840	$30	$285.4K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	860	$100	$81.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	570	$90	$53.1K
67041	In this procedure, the provider removes scar tissue from the retinal membrane that obscures vision. He removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical…	50	$890	$47.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,430	$30	$42.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	330	$90	$30K
67036	The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana.	40	$630	$25K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	330	$60	$21.1K
J9035	Injection, bevacizumab, 10 mg	350	$60	$19.3K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Minnesota Distribution

Alexander Ringeisen — 3 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Minnesota

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	21	40	580	$690	$743.4K
J2777	9	20	6,120	$30	$411.1K
67028	18	80	420	$90	$64.8K
67042	8	10	20	$1,300	$48K
67036	2	10	20	$1,140	$37.5K
67041	1	10	20	$1,090	$25.1K
J7999	4	20	40	$210	$21.2K
J9035	15	40	220	$50	$16.9K
92014	87	830	100	$80	$11.9K
92012	22	200	60	$60	$8.8K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Alexander Ringeisen, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Vitreoretinal Surgery PLLC	MN	Ophthalmology Physician	$0	$27.8M
David Williams	MN	Retina Specialist (Ophthalmology) Physician	$5.5M	$0
David Parke	MN	Ophthalmology Physician	$4.8M	$0
Sundeep Dev	MN	Ophthalmology Physician	$4.5M	$0
John Davies	MN	Ophthalmology Physician	$3.9M	$0
Polly Quiram	MN	Ophthalmology Physician	$3.7M	$0
Geoffrey Emerson	MN	Retina Specialist (Ophthalmology) Physician	$3.3M	$0
Chad Laurich	SD	Vascular Surgery Physician	$3.2M	$0
NPI 1588636484	—	—	$3.2M	$0
Robert Mittra	MN	Ophthalmology Physician	$3.1M	$0

Nearby Providers

Other providers in the same ZIP code as Alexander Ringeisen, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Valhalla Place, LLC	MN	Community/Behavioral Health Agency	$581K	$22.1M
St. Croix Psychiatric, LLC	MN	Psychiatry Physician	$0	$19.9M
Kubei Holding Group Inc	MN	Community/Behavioral Health Agency	$0	$15.5M
Holistic Home Care LLC	MN	Home Health Agency	$0	$14.7M
Redeemer Services, Inc.	MN	Case Management Agency	$0	$14.3M
Greatercare Facilities, LLC	MN	Home Health Agency	$0	$10.4M
B Tek, LLC	MN	Clinical Medical Laboratory	$0	$10.2M
Summit Orthopedics, Ltd	MN	Orthopaedic Surgery Physician	$0	$6.7M
Healtheast Woodwinds Hospital	MN	General Acute Care Hospital	$0	$6.2M
Allina Health System	MN	Family Medicine Physician	$0	$5.5M

Alexander Ringeisen — Billing Profile & Reimbursement Data

Sign up for Alexander Ringeisen — Billing Profile & Reimbursement Data policy alerts

Alexander Ringeisen — Billing Profile & Reimbursement Data

Sign up for Alexander Ringeisen — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References